Ophthalmology Market Size, Share, and Trends 2024 to 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw End User Procurement Analysis 

4.3.2. Sales and Distribution Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Ophthalmology Market 

5.1. COVID-19 Landscape: Ophthalmology Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Ophthalmology Market, By Product

8.1. Ophthalmology Market Revenue and Volume, by Product, 2024-2034

8.1.1. Device

8.1.1.1. Market Revenue and Volume Forecast (2021-2034)

8.1.2. Drugs

8.1.2.1. Market Revenue and Volume Forecast (2021-2034)

8.1.3. Others

8.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 9. Global Ophthalmology Market, By Disease

9.1. Ophthalmology Market Revenue and Volume, by Disease, 2024-2034

9.1.1. Glaucoma

9.1.1.1. Market Revenue and Volume Forecast (2021-2034)

9.1.2. Cataract

9.1.2.1. Market Revenue and Volume Forecast (2021-2034)

9.1.3. Age-Related Macular Degeneration

9.1.3.1. Market Revenue and Volume Forecast (2021-2034)

9.1.4. Inflammatory Diseases

9.1.4.1. Market Revenue and Volume Forecast (2021-2034)

9.1.5. Refractive Disorders

9.1.5.1. Market Revenue and Volume Forecast (2021-2034)

9.1.6. Others

9.1.6.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 10. Global Ophthalmology Market, By Distribution Channel

10.1. Ophthalmology Market Revenue and Volume, by Distribution Channel, 2024-2034

10.1.1. Direct Tender

10.1.1.1. Market Revenue and Volume Forecast (2021-2034)

10.1.2. Retail Sales

10.1.2.1. Market Revenue and Volume Forecast (2021-2034)

10.1.3. Others

10.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 11. Global Ophthalmology Market, By End User

11.1. Ophthalmology Market Revenue and Volume, by End User, 2024-2034

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast (2021-2034)

11.1.2. Clinics

11.1.2.1. Market Revenue and Volume Forecast (2021-2034)

11.1.3. Home Healthcare

11.1.3.1. Market Revenue and Volume Forecast (2021-2034)

11.1.4. Others

11.1.4.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 12. Global Ophthalmology Market, By End-User

12.1. Ophthalmology Market Revenue and Volume, by End-User, 2024-2034

12.1.1. Original Equipment Manufacturer

12.1.1.1. Market Revenue and Volume Forecast (2021-2034)

12.1.2. Aftermarket

12.1.2.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 13. Global Ophthalmology Market, By Actuators

13.1. Ophthalmology Market Revenue and Volume, by Actuators, 2024-2034

13.1.1. Hydraulic

13.1.1.1. Market Revenue and Volume Forecast (2021-2034)

13.1.2. Pneumatic

13.1.2.1. Market Revenue and Volume Forecast (2021-2034)

13.1.3. Electric

13.1.3.1. Market Revenue and Volume Forecast (2021-2034)

Chapter 14. Global Ophthalmology Market, Regional Estimates and Trend Forecast

14.1. North America

14.1.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.1.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.1.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.1.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.1.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.1.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.1.7. U.S.

14.1.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.1.7.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.1.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.1.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.1.8. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.1.8.1. Market Revenue and Volume Forecast, by Actuators (2021-2034) 

14.1.9. Rest of North America

14.1.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.1.9.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.1.9.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.1.9.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.1.10. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.1.11. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.1.11.1.

14.2. Europe

14.2.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.2.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.2.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.2.4. Market Revenue and Volume Forecast, by End User (2021-2034) 

14.2.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.2.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.2.7.

14.2.8. UK

14.2.8.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.2.8.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.2.8.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.2.9. Market Revenue and Volume Forecast, by End User (2021-2034) 

14.2.10. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.2.10.1. Market Revenue and Volume Forecast, by Actuators (2021-2034) 

14.2.11. Germany

14.2.11.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.2.11.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.2.11.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.2.12. Market Revenue and Volume Forecast, by End User (2021-2034)

14.2.13. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.2.14. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.2.14.1.

14.2.15. France

14.2.15.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.2.15.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.2.15.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.2.15.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.2.16. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.2.16.1. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.2.17. Rest of Europe

14.2.17.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.2.17.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.2.17.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.2.17.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.2.18. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.2.18.1. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.3. APAC

14.3.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.3.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.3.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.3.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.3.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.3.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.3.7. India

14.3.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.3.7.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.3.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.3.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.3.8. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.3.9. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.3.10. China

14.3.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.3.10.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.3.10.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.3.10.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.3.11. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.3.11.1. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.3.12. Japan

14.3.12.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.3.12.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.3.12.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.3.12.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.3.12.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.3.12.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.3.13. Rest of APAC

14.3.13.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.3.13.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.3.13.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.3.13.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.3.13.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.3.13.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.4. MEA

14.4.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.4.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.4.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.4.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.4.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.4.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.4.7. GCC

14.4.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.4.7.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.4.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.4.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.4.8. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.4.9. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.4.10. North Africa

14.4.10.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.4.10.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.4.10.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.4.10.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.4.11. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.4.12. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.4.13. South Africa

14.4.13.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.4.13.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.4.13.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.4.13.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.4.13.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.4.13.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.4.14. Rest of MEA

14.4.14.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.4.14.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.4.14.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.4.14.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.4.14.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.4.14.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.5. Latin America

14.5.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.5.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.5.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.5.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.5.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.5.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.5.7. Brazil

14.5.7.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.5.7.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.5.7.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.5.7.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.5.8. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.5.8.1. Market Revenue and Volume Forecast, by Actuators (2021-2034)

14.5.9. Rest of LATAM

14.5.9.1. Market Revenue and Volume Forecast, by Product (2021-2034)

14.5.9.2. Market Revenue and Volume Forecast, by Disease (2021-2034)

14.5.9.3. Market Revenue and Volume Forecast, by Distribution Channel (2021-2034)

14.5.9.4. Market Revenue and Volume Forecast, by End User (2021-2034)

14.5.9.5. Market Revenue and Volume Forecast, by End-User (2021-2034)

14.5.9.6. Market Revenue and Volume Forecast, by Actuators (2021-2034)

Chapter 15. Company Profiles

15.1. Alcon, Inc.

15.1.1. Company Overview

15.1.2. Product Offerings

15.1.3. Financial Performance

15.1.4. Recent Initiatives

15.2. Bausch Health Companies Inc.

15.2.1. Company Overview

15.2.2. Product Offerings

15.2.3. Financial Performance

15.2.4. Carl Zeiss Meditec AG

15.3. BorgWarner Inc.

15.3.1. Company Overview

15.3.2. Product Offerings

15.3.3. Financial Performance

15.3.4. Recent Initiatives

15.4. Essilor International S.A.

15.4.1. Company Overview

15.4.2. Product Offerings

15.4.3. Financial Performance

15.4.4. Recent Initiatives

15.5. Haag-Streit AG.

15.5.1. Company Overview

15.5.2. Product Offerings

15.5.3. Financial Performance

15.5.4. Recent Initiatives

15.6. Johnson & Johnson Vision Care, Inc

15.6.1. Company Overview

15.6.2. Product Offerings

15.6.3. Financial Performance

15.6.4. Recent Initiatives

15.7. NIDEK CO., LTD.

15.7.1. Company Overview

15.7.2. Product Offerings

15.7.3. Financial Performance

15.7.4. Recent Initiatives

15.8. Novartis AG

15.8.1. Company Overview

15.8.2. Product Offerings

15.8.3. Financial Performance

15.8.4. Recent Initiatives

15.9. STAAR Surgical Company

15.9.1. Company Overview

15.9.2. Product Offerings

15.9.3. Financial Performance

15.9.4. Recent Initiatives

15.10. Topcon Corporation

15.10.1. Company Overview

15.10.2. Product Offerings

15.10.3. Financial Performance

15.10.4. Recent Initiatives

Chapter 16. Research Methodology

16.1. Primary Research

16.2. Secondary Research

16.3. Assumptions

Chapter 17. Appendix

17.1. About Us

17.2. Glossary of Terms